About Cubresa
Cubresa is a Healthcare company based in Winnipeg (Canada) founded in 2011. It operates as a nuclear imaging products. Cubresa has raised $4.5 million across 3 funding rounds from investors including Manitoba Technology Accelerator. Cubresa offers products and services including BrainPET, NuPET, and NuPET Bio. Its focus areas include Life Sciences, Imaging Diagnostics and Nuclear Imaging. Its legal entity is Cubresa Inc. Its competitors include Mercurius Health, Niowave, Mediso, Clear Vascular and PETsys Electronics and 4 more; 3 of its 9 listed competitors have raised funding.
Company details
Cubresa was founded in 2011 in Winnipeg, Canada, within the nuclear imaging sector. Preclinical PET and SPECT scanners are developed and manufactured to enable non-invasive visualization of molecular biochemical processes. The portfolio includes Compact SPECT scanners and NuPET in-bore PET systems that integrate with existing MRI instruments for hybrid imaging platforms. SensL SPM chips are incorporated for reliable operation and performance.
- Headquarters Winnipeg, Canada
- SectorsHealthcare
- Phone•••• ••••
- Website cubresa.com
- Social LinkedIn X Facebook YouTube
- Legal Name Cubresa Inc.
- Total Equity Funding$4.5M (USD)
in 3 rounds
- Latest Funding Round$3.5M (USD), Series A
Dec 2015
- Investors
Products & Services of Cubresa
Cubresa offers a comprehensive portfolio of products and services, including BrainPET, NuPET, and NuPET Bio.
PET insert for MRI scanners used in human brain research.
Portable PET system for animal studies and research applications.
Specialized PET scanner for infectious disease research in labs.
Apps and channels of Cubresa
its YouTube channel Cubresa has 12 subscribers.
Funding Insights of Cubresa
Cubresa has successfully raised a total of $4.5M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $3.5 million completed in December 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.5M
- Total Rounds 3
- Last Round Series A — $3.5M
- First Round $500,000
(Jun 2013)
- Investors Count 1
All 3 funding rounds of Cubresa with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2015 | $3.5M | Series A | – | – | – |
| Jul 2013 | $500,000 | Series A | – | Manitoba Technology Accelerator | – |
| Jun 2013 | $500,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Cubresa
Cubresa has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Manitoba Technology Accelerator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | mbtechaccelerator.com | - |
Investor details for Cubresa
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Cubresa
3 dated milestones of Cubresa across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Cubresa is founded.
- Funding First funding round of $500K.
- Funding Latest funding round, Series A, of $3.5M.
Competitors of Cubresa
Cubresa has 9 listed competitors in our database, 3 of them funded. They include Mercurius Health, Niowave, Mediso, Clear Vascular and PETsys Electronics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mercuriushealth.com | 2013 | Porto Salvo, Portugal | – | – | Resources and training for radiotherapy and nuclear medicine are provided. | |
| niowaveinc.com | 2006 | United States | $9.95M | – | Devices and radioisotopes for nuclear imaging are provided by Niowave. | |
| mediso.com | 1990 | Budapest, Hungary | – | – | Nuclear medicine and hybrid imaging equipment | |
| clearvascular.com | 2005 | The Woodlands, United States | $3.16M | – | Develops pharmaceutical products for treating cardiovascular conditions. | |
| petsyselectronics.com | 2013 | Oeiras, Portugal | – | – | Gamma ray detectors are developed for medical PET scanners. | |
| cmr-naviscan.com | 2003 | Carlsbad, United States | – | – | High-resolution PET systems for breast cancer imaging are provided. | |
| bestcyclotron.com | 2009 | – | – | – | Provides comprehensive design and production solutions for commercial cyclotrons. | |
| seraclifesciences.com | 2017 | London, United Kingdom | $2.04M | – | Molecular imaging devices are developed for arthritis diagnostics. | |
| gmisotope.com | 2013 | Henderson, United States | – | – | Specializes in medical isotope production and specialty metal processing. |
Detailed competitors of Cubresa
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cubresa
The website of Cubresa (cubresa.com) receives about 2.2K visits a month.
- Monthly visits2.2K
▲ 229.8% vs previous month
Top companies in Imaging Diagnostics
10 companies that operate in the same segment as Cubresa (Imaging Diagnostics), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Handheld ultrasound devices are developed for whole-body medical imaging. | 2011 | Guilford, Connecticut, United States | USD 350 M | USD 97.61 M | 464 | |
Technology tools and systems for molecular scale are developed. | 1959 | Abingdon, Oxfordshire, United Kingdom | – | USD 648.1 M | – | |
MR-interfaced ultrasound devices for cancer and neurology treatments are provided. | 1999 | Tirat Carmel, Haifa District, Israel | USD 574.2 M | – | 541 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | – | 91 | |
Manufacturer of imaging and surgical products | 1919 | Tokyo, Tokyo, Japan | – | USD 6.49 B | 35,933 | |
Ultrasound images are analyzed via AI-based software provided by Exo. | 2015 | Redwood City, California, United States | USD 463.39 M | – | – | |
Planar X-ray radiology products for diagnostic imaging are supplied. | 2000 | Oxford, Oxfordshire, United Kingdom | USD 43.43 M | USD 1.04 M | 50 | |
Digital X-ray sources are developed by Nanox for cloud-based diagnostics. | 2004 | Jerusalem, Jerusalem District, Israel | USD 110.72 M | USD 13.02 M | 165 | |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies. | 2007 | Los Angeles, California, United States | USD 59.64 M | – | – | |
Portable wireless ultrasound systems are developed for medical imaging. | 2014 | Burnaby, British Columbia, Canada | USD 21.87 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cubresa
Complete news archive for Cubresa
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cubresa
Cubresa was founded in 2011 and raised its 1st funding round 2 years after it was founded.
Cubresa is headquartered in Winnipeg, Canada. It is registered at Winnipeg, Manitoba, Canada.
Cubresa is a funded company, having raised a total of $4.5M across 3 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Jun 2013.
Cubresa was founded in 2011 in Winnipeg, Canada, within the nuclear imaging sector. Preclinical PET and SPECT scanners are developed and manufactured to enable non-invasive visualization of molecular biochemical processes. The portfolio includes Compact SPECT scanners and NuPET in-bore PET systems that integrate with existing MRI instruments for hybrid imaging platforms. SensL SPM chips are incorporated for reliable operation and performance.
Cubresa's top competitors include Niowave, Mediso and Mercurius Health.
Cubresa offers BrainPET, NuPET, and NuPET Bio.
Cubresa has 1 investor. Key investors include Manitoba Technology Accelerator.
Cubresa operates through Cubresa Inc..